Absract
The inhibitory glycine receptor is a ligand‐gated chloride channel of the cys‐loop receptor family. As a chloride‐selective channel, it mediates rapid synaptic inhibition in mammalian spinal cord, brainstem, higher brain centres and nonneuronal tissues. In recent years, our understanding of glycine receptors has steadily grown, adding considerable depth to our knowledge of receptor function, structure, cellular trafficking and tissue distribution. Furthermore, new roles for glycinergic transmission in higher brain function have been uncovered. Glycine receptors should no longer be considered only as mediators of spinal reflexes, but were also found to play an important role in the modulation of higher brain function, including vision, hearing and pain signalling. The identification of novel agonists and modulators underlines the relevance of the inhibitory glycine receptor as a therapeutic target. This review extends a previous article of this series and highlights key developments in glycine receptor research over the past 2–3 years.
Key Concepts:
Glycine receptors are key mediators of rapid synaptic inhibition in mammalian spinal cord and higher brain centres.
Glycine receptors are members of the cys‐loop family of ligand‐gated ion channel receptors.
Glycinergic signalling is involved in motor control, pain signalling, vision, hearing and other brain functions.
Mutations in glycine receptor genes underlie human hyperekplexia and related myoclonic diseases.
New modulators of glycine receptor function are rare and of considerable medicinal interest.